Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Notices 52459 

Frequency of response: Every four 

years. 

Estimated total average number of 

responses for each respondent: 7.38. 

Estimated total annual burden hours: 

735,456 hours. 

Estimated total annual costs: 

$79,267,359. This includes an estimated 

burden cost of $79,267,359 and an 

estimated cost of $0 for capital 

investment or maintenance and 

operational costs. 

III. Are there changes in the estimates 

from the last approval? 

There is an increase in total annual 

costs compared with that identified in 

the ICR currently approved by OMB. 

The primary reason for changes in 

respondent burden and cost are a result 

of changes from finalized regulatory 

actions in 2020. In addition, the 

increase in the respondent burden and 

agency costs were caused by an increase 

in the hourly wages and a change in the 

methodology to calculate loaded wages 

(wages plus fringe benefits and 

overhead). Please refer to Handbook on 

Valuing Changes in Time Use Induced 

by Regulatory Requirements and Other 

U.S. EPA Actions. This change is an 

adjustment. 

In addition, OMB has requested that 

EPA move towards using the 18- 

question format for ICR Supporting 

Statements used by other federal 

agencies and departments and is based 

on the submission instructions 

established by OMB in 1995, replacing 

the alternate format developed by EPA 

and OMB prior to 1995. The Agency 

does not expect this change in format to 

result in substantive changes to the 

information collection activities or 

related estimated burden and costs. 

IV. What is the next step in the process 

for this ICR? 

EPA will consider the comments 

received and amend the ICR as 

appropriate. The final ICR package will 

then be submitted to OMB for review 

and approval pursuant to 5 CFR 

1320.12. EPA will issue another Federal 

Register document pursuant to 5 CFR 

1320.5(a)(1)(iv) to announce the 

submission of the ICR to OMB and the 

opportunity to submit additional 

comments. If you have any questions 

about this ICR or the approval process, 

please contact the person listed under 

FOR FURTHER INFORMATION CONTACT. 

Authority: 15 U.S.C. 2601 et seq. 

Dated: September 15, 2021. 

Michal Freedhoff, 

Assistant Administrator, Office of Chemical 

Safety and Pollution Prevention. 

[FR Doc. 2021–20355 Filed 9–20–21; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2021–0146; FRL–8682–04– 

OCSPP] 

Certain New Chemicals or Significant 

New Uses; Statements of Findings for 

July 2021 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Toxic Substances Control 

Act (TSCA) requires EPA to publish in 

the Federal Register a statement of its 

findings after its review of certain TSCA 

notices when EPA makes a finding that 

a new chemical substance or significant 

new use is not likely to present an 

unreasonable risk of injury to health or 

the environment. Such statements apply 

to premanufacture notices (PMNs), 

microbial commercial activity notices 

(MCANs), and significant new use 

notices (SNUNs) submitted to EPA 

under TSCA. This document presents 

statements of findings made by EPA on 

such submissions during the period 

from July 1, 2021 to July 31, 2021. 

FOR FURTHER INFORMATION CONTACT:

For technical information contact: 

Rebecca Edelstein, Chemical Control 

Division (7405M), Office of Pollution 

Prevention and Toxics, Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW, Washington, DC 20460–0001; 

telephone number: 202–564–1667 email 

address: Edelstein.rebecca@epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general. As such, the Agency has not 

attempted to describe the specific 

entities that this action may apply to. 

Although others may be affected, this 

action applies directly to the submitters 

of the PMNs addressed in this action. 

B. How can I get copies of this document 

and other related information? 

The docket for this action, identified 

by docket identification (ID) number 

EPA–HQ–OPPT–2021–0146, is available 

at http://www.regulations.gov. Due to 

the public health concerns related to 

COVID–19, the EPA Docket Center 

(EPA/DC) and Reading Room is closed 

to visitors with limited exceptions. The 

staff continues to provide remote 

customer service via email, phone, and 

webform. For the latest status 

information on EPA/DC services and 

docket access, visit https://

www.epa.gov/dockets. 

II. What action is the agency taking? 

This document lists the statements of 

findings made by EPA after review of 

notices submitted under TSCA section 

5(a) that certain new chemical 

substances or significant new uses are 

not likely to present an unreasonable 

risk of injury to health or the 

environment. This document presents 

statements of findings made by EPA 

during the period from July 1, 2021 to 

July 31, 2021. 

III. What is the Agency’s authority for 

taking this action? 

TSCA section 5(a)(3) requires EPA to 

review a TSCA section 5(a) notice and 

make one of the following specific 

findings: 

• The chemical substance or 

significant new use presents an 

unreasonable risk of injury to health or 

the environment; 

• The information available to EPA is 

insufficient to permit a reasoned 

evaluation of the health and 

environmental effects of the chemical 

substance or significant new use; 

• The information available to EPA is 

insufficient to permit a reasoned 

evaluation of the health and 

environmental effects and the chemical 

substance or significant new use may 

present an unreasonable risk of injury to 

health or the environment; 

• The chemical substance is or will 

be produced in substantial quantities, 

and such substance either enters or may 

reasonably be anticipated to enter the 

environment in substantial quantities or 

there is or may be significant or 

substantial human exposure to the 

substance; or 

• The chemical substance or 

significant new use is not likely to 

present an unreasonable risk of injury to 

health or the environment. 

Unreasonable risk findings must be 

made without consideration of costs or 

other non-risk factors, including an 

unreasonable risk to a potentially 

exposed or susceptible subpopulation 

identified as relevant under the 

conditions of use. The term ‘‘conditions 

of use’’ is defined in TSCA section 3 to 

mean ‘‘the circumstances, as determined 

by the Administrator, under which a 

chemical substance is intended, known, 

or reasonably foreseen to be 

manufactured, processed, distributed in 

commerce, used, or disposed of.’’ 

EPA is required under TSCA section 

5(g) to publish in the Federal Register 


lotter on DSK11XQN23PROD with NOTICES1
52460 Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Notices 

a statement of its findings after its 

review of a TSCA section 5(a) notice 

when EPA makes a finding that a new 

chemical substance or significant new 

use is not likely to present an 

unreasonable risk of injury to health or 

the environment. Such statements apply 

to PMNs, MCANs, and SNUNs 

submitted to EPA under TSCA section 

5. 

Anyone who plans to manufacture 

(which includes import) a new chemical 

substance for a non-exempt commercial 

purpose and any manufacturer or 

processor wishing to engage in a use of 

a chemical substance designated by EPA 

as a significant new use must submit a 

notice to EPA at least 90 days before 

commencing manufacture of the new 

chemical substance or before engaging 

in the significant new use. 

The submitter of a notice to EPA for 

which EPA has made a finding of ‘‘not 

likely to present an unreasonable risk of 

injury to health or the environment’’ 

may commence manufacture of the 

chemical substance or manufacture or 

processing for the significant new use 

notwithstanding any remaining portion 

of the applicable review period. 

IV. Statements of Administrator 

Findings Under TSCA Section 5(a)(3)(C) 

In this unit, EPA provides the 

following information (to the extent that 

such information is not claimed as 

Confidential Business Information 

(CBI)) on the PMNs, MCANs and 

SNUNs for which, during this period, 

EPA has made findings under TSCA 

section 5(a)(3)(C) that the new chemical 

substances or significant new uses are 

not likely to present an unreasonable 

risk of injury to health or the 

environment: 

• EPA case number assigned to the 

TSCA section 5(a) notice. 

• Chemical identity (generic name if 

the specific name is claimed as CBI). 

• Website link to EPA’s decision 

document describing the basis of the 

‘‘not likely to present an unreasonable 

risk’’ finding made by EPA under TSCA 

section 5(a)(3)(C). 

EPA case No. Chemical identity Website link 

J–21–0014, J–21–0015, J–21– 

0016, J–21–0017, J–21–0018.

Chromosomally modified Saccharomyces cerevisiae 

(Generic Name).

https://www.epa.gov/system/files/documents/2021- 

07/j-21-0014-0018_determination_noncbi_final.pdf. 

J–21–0019 .................................... Strain of Escherichia coli modified with genetically-stable, plasmid-borne DNA for the production of 

plasmid-borne DNA (Generic Name).

https://www.epa.gov/system/files/documents/2021- 

07/j-21-0019_determination_non-cbi_final.pdf. 

P–21–0020 .................................... Alkanedioic acid, dialkyl ester, polymer with dialkylalkanediol, alkyl (substituted alkyl)-alkanediol and 

heteropolycycle (Generic Name).

https://www.epa.gov/system/files/documents/2021- 

07/p-21-0020_determination_non-cbi_final.pdf. 

P–21–0037, ...................................

P–21–0038 ....................................

P–21–0037: [1,1’-Biphenyl]-3,3’,4,4’-tetracarboxamide, 

N3,N3’,N4,N4’-tetraoctyl; CASRN: 2169674–18–2 

(Specific)..

P–21–0038: [1,1’-Biphenyl]-3,3’,4,4’-tetracarboxamide, 

N3, N3’, N4, N4’-tetradodecyl; CASRN: 2413095–68– 

6 (Specific).

https://www.epa.gov/system/files/documents/2021- 

07/p-21-0037-0038_determination_noncbi_final.pdf. 

P–21–0085 .................................... 1-Propanethiol, 3-(triethoxysilyl)-, reaction products with 

polybutadiene; CASRN: 2109699–92–3 (Specific).

https://www.epa.gov/system/files/documents/2021- 

08/p-21-0085_determination_noncbi_final_1.pdf. 

Authority: 15 U.S.C. 2601 et seq. 

Dated: September 13, 2021. 

Madison Le, 

Director, New Chemicals Division, Office of 

Pollution Prevention and Toxics. 

[FR Doc. 2021–20356 Filed 9–20–21; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPP–2021–0083; FRL–8793–02– 

OCSPP] 

Pesticide Product Registration; 

Receipt of Applications for New Active 

Ingredients (September 2021) 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: EPA has received applications 

to register pesticide products containing 

active ingredients not included in any 

currently registered pesticide products. 

Pursuant to the Federal Insecticide, 

Fungicide, and Rodenticide Act 

(FIFRA), EPA is hereby providing notice 

of receipt and opportunity to comment 

on these applications. 

DATES: Comments must be received on 

or before October 21, 2021. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number and the File Symbol of interest 

as shown in the body of this document, 

online at http://www.regulations.gov. 

Follow the online instructions for 

submitting comments. Do not submit 

electronically any information you 

consider to be Confidential Business 

Information (CBI) or other information 

whose disclosure is restricted by statute. 

Additional instructions on commenting 

or visiting the docket, along with more 

information about dockets generally, is 

available at https://www.epa.gov/ 

dockets/about-epa-dockets. 

Due to the public health concerns 

related to COVID–19, the EPA/DC and 

Reading Room is closed to visitors with 

limited exceptions. The staff continues 

to provide remote customer service via 

email, phone, and webform. For the 

latest status information on the EPA/DC 

and docket access, visit https://

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: 

Charles Smith, Biopesticides and 

Pollution Prevention Division (7511P), 

main telephone number: (703) 305– 

7090, email address: BPPDFRNotices@

epa.gov; The mailing address for each 

contact person is: Office of Pesticide 

Programs, Environmental Protection 

Agency, 1200 Pennsylvania Ave. NW, 

Washington, DC 20460–0001. As part of 

the mailing address, include the contact 

person’s name, division, and mail code. 

The division to contact is listed at the 

end of each pesticide petition summary. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you are an agricultural 

producer, food manufacturer, or 

pesticide manufacturer. The following 

list of North American Industrial 

Classification System (NAICS) codes is 

not intended to be exhaustive, but rather 


lotter on DSK11XQN23PROD with NOTICES1